CORRIGAN MARK

CIK 00012506619 companiesMARLBOROUGH, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001250661

Recent Transactions

50 trades

Sale
Wave Life Sciences Ltd.$WVE
Ordinary Shares
2025-12-08$13.09/sh−9,600→ 35,330 total
Sale
Wave Life Sciences Ltd.$WVE
Ordinary Shares
2025-12-08$14.06/sh−6,515→ 28,815 total
Award
Wave Life Sciences Ltd.$WVE
Ordinary Shares
2025-08-11+12,700→ 44,930 total
Award
Wave Life Sciences Ltd.$WVE
Share Option (right to buy)
2025-08-11+76,200→ 76,200 total
Award
Wave Life Sciences Ltd.$WVE
Ordinary Shares
2024-08-12+32,230→ 32,230 total
Award
Wave Life Sciences Ltd.$WVE
Share Option (right to buy)
2024-08-12+64,460→ 64,460 total
Award
TREVENA INC
Stock Option (Right to Buy)
2024-06-13+13,700→ 13,700 total
Award
Wave Life Sciences Ltd.$WVE
Share Option (right to buy)
2023-08-07+45,000→ 45,000 total
Award
TREVENA INC
Stock Option (Right to Buy)
2023-07-18+34,250→ 34,250 total
Award
Wave Life Sciences Ltd.$WVE
Share Option (right to buy)
2022-08-15+21,000→ 21,000 total
Sale
Nabriva Therapeutics plc
Ordinary Shares
2022-08-02$0.19/sh−10,297→ 7,203 total
Award
Wave Life Sciences Ltd.$WVE
Share Option (right to buy)
2021-08-16+21,000→ 21,000 total
Award
Nabriva Therapeutics plc
Ordinary Shares
2021-07-28+17,500→ 17,500 total
Award
Nabriva Therapeutics plc
Share Options
2021-07-28−35,000→ 35,000 total
Award
Nabriva Therapeutics plc
Share Options
2021-06-02+10,500→ 10,500 total
Award
Wave Life Sciences Ltd.$WVE
Share Option (right to buy)
2020-08-18+10,500→ 10,500 total
Award
Wave Life Sciences Ltd.$WVE
Share Option (right to buy)
2019-09-04+21,000→ 21,000 total
Award
Nabriva Therapeutics plc
Stock Option
2019-07-31+35,000→ 35,000 total
Award
NOVELION THERAPEUTICS INC.
Stock Option (Right to Buy)
2018-08-09+50,000→ 50,000 total
Award
Nabriva Therapeutics plc
Stock Option
2018-05-02+29,000→ 29,000 total
Award
Nabriva Therapeutics plc
Stock Option
2017-09-15+10,100→ 10,100 total
Other
Nabriva Therapeutics Legacy plc
Stock Option
2017-06-23+20,200→ 20,200 total
Other
Nabriva Therapeutics Legacy plc
Stock Option
2017-06-23+10,100→ 10,100 total
Award
NOVELION THERAPEUTICS INC.
Stock Option (Right to Buy)
2017-03-30+9,600→ 9,600 total
Award
NOVELION THERAPEUTICS INC.
Stock Option (Right to Buy)
2017-03-30+9,600→ 9,600 total
Disposition to Issuer
CoLucid Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-03-01$40.26/sh−8,897→ 0 total
Disposition to Issuer
CoLucid Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-03-01$42.71/sh−8,114→ 0 total
Award
CoLucid Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2016-05-10+8,897→ 8,897 total
Award
CoLucid Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2015-10-27+8,114→ 8,114 total
Award
EPIRUS Biopharmaceuticals, Inc.
Non-Employee Stock Option (Right to Buy)
2015-06-05+9,000→ 9,000 total
Disposition to Issuer
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2015-01-21−9,472→ 0 total
Disposition to Issuer
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2015-01-21−6,202→ 0 total
Disposition to Issuer
CUBIST PHARMACEUTICALS INC
Restricted Stock Units
2015-01-21−1,687→ 0 total
Other
CUBIST PHARMACEUTICALS INC
Common Stock
2015-01-21$102.00/sh−7,501→ 0 total
Disposition to Issuer
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2015-01-21−8,370→ 0 total
Disposition to Issuer
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2015-01-21−16,519→ 0 total
Disposition to Issuer
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2015-01-21−9,367→ 0 total
Tax Payment
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2014-07-15$11.80/sh−14,597→ 21,859 total
Exercise/Conversion
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2014-02-27−5,000→ 0 total
Sale
CUBIST PHARMACEUTICALS INC
Common Stock
2014-02-27$80.00/sh−5,000→ 5,498 total
Exercise/Conversion
CUBIST PHARMACEUTICALS INC
Common Stock
2014-02-27$18.22/sh+5,000→ 10,498 total
Award
EPIRUS Biopharmaceuticals, Inc.
Stock Option (Right to Buy)
2014-02-10+250,000→ 250,000 total
Award
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2014-02-10+250,000→ 364,567 total
Tax Payment
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2014-01-15$1.66/sh−18,079→ 114,567 total
Tax Payment
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2014-01-03$1.22/sh−8,035→ 132,646 total
Award
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2013-06-12+8,370→ 8,370 total
Award
CUBIST PHARMACEUTICALS INC
Common Stock
2013-06-12+995→ 5,498 total
Award
CUBIST PHARMACEUTICALS INC
Restricted Stock Units
2013-06-12+1,104→ 1,104 total
Exercise/Conversion
CUBIST PHARMACEUTICALS INC
Common Stock
2013-06-06+1,347→ 4,503 total
Exercise/Conversion
CUBIST PHARMACEUTICALS INC
Restricted Stock Units
2013-06-06−1,347→ 0 total

CORRIGAN MARK

Recent Transactions

Companies

Recent Filings

Address